Question-and-Answer SessionPerfect. Let's dive right in. So last week, despite reporting remarkably strong BRINSUPRI numbers, sales of $208 million, up 44% sequentially, there were some concerns raised over the discontinuation rates. So thus far, can you comment on the discontinuation rates and how that tracks to your expectations? And I guess, relative to similar oral small molecules?William LewisPresident, CEO & Chairman Yes. So maybe I can just take a moment to set the stage. When we put out the addition ...